529 related articles for article (PubMed ID: 29522212)
21. Electroencephalogram paroxysmal θ characterizes cataplexy in mice and children.
Vassalli A; Dellepiane JM; Emmenegger Y; Jimenez S; Vandi S; Plazzi G; Franken P; Tafti M
Brain; 2013 May; 136(Pt 5):1592-608. PubMed ID: 23616586
[TBL] [Abstract][Full Text] [Related]
22. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.
Chemelli RM; Willie JT; Sinton CM; Elmquist JK; Scammell T; Lee C; Richardson JA; Williams SC; Xiong Y; Kisanuki Y; Fitch TE; Nakazato M; Hammer RE; Saper CB; Yanagisawa M
Cell; 1999 Aug; 98(4):437-51. PubMed ID: 10481909
[TBL] [Abstract][Full Text] [Related]
23. Selective REM sleep deprivation in narcolepsy.
Vu MH; Hurni C; Mathis J; Roth C; Bassetti CL
J Sleep Res; 2011 Mar; 20(1 Pt 1):50-6. PubMed ID: 20880101
[TBL] [Abstract][Full Text] [Related]
24. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
25. Continuous intrathecal orexin delivery inhibits cataplexy in a murine model of narcolepsy.
Kaushik MK; Aritake K; Imanishi A; Kanbayashi T; Ichikawa T; Shimizu T; Urade Y; Yanagisawa M
Proc Natl Acad Sci U S A; 2018 Jun; 115(23):6046-6051. PubMed ID: 29784823
[TBL] [Abstract][Full Text] [Related]
26. A circuit perspective on narcolepsy.
Adamantidis AR; Schmidt MH; Carter ME; Burdakov D; Peyron C; Scammell TE
Sleep; 2020 May; 43(5):. PubMed ID: 31919524
[TBL] [Abstract][Full Text] [Related]
27. Deficiency of orexin signaling during sleep is involved in abnormal REM sleep architecture in narcolepsy.
Ito H; Fukatsu N; Rahaman SM; Mukai Y; Izawa S; Ono D; Kilduff TS; Yamanaka A
Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2301951120. PubMed ID: 37796986
[TBL] [Abstract][Full Text] [Related]
28. High-amplitude theta wave bursts during REM sleep and cataplexy in hypocretin-deficient narcoleptic mice.
Bastianini S; Silvani A; Berteotti C; Lo Martire V; Zoccoli G
J Sleep Res; 2012 Apr; 21(2):185-8. PubMed ID: 21883592
[TBL] [Abstract][Full Text] [Related]
29. Paradoxical (REM) sleep deprivation in mice using the small-platforms-over-water method: polysomnographic analyses and melanin-concentrating hormone and hypocretin/orexin neuronal activation before, during and after deprivation.
Arthaud S; Varin C; Gay N; Libourel PA; Chauveau F; Fort P; Luppi PH; Peyron C
J Sleep Res; 2015 Jun; 24(3):309-19. PubMed ID: 25524602
[TBL] [Abstract][Full Text] [Related]
30. First rapid eye movement sleep periods and sleep-onset rapid eye movement periods in sleep-stage sequencing of hypersomnias.
Drakatos P; Kosky CA; Higgins SE; Muza RT; Williams AJ; Leschziner GD
Sleep Med; 2013 Sep; 14(9):897-901. PubMed ID: 23764105
[TBL] [Abstract][Full Text] [Related]
31. Narcolepsies, update in 2023.
Barateau L; Pizza F; Chenini S; Peter-Derex L; Dauvilliers Y
Rev Neurol (Paris); 2023 Oct; 179(7):727-740. PubMed ID: 37634997
[TBL] [Abstract][Full Text] [Related]
32. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives.
Overeem S; Mignot E; van Dijk JG; Lammers GJ
J Clin Neurophysiol; 2001 Mar; 18(2):78-105. PubMed ID: 11435802
[TBL] [Abstract][Full Text] [Related]
33. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
Knudsen S; Gammeltoft S; Jennum PJ
Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
[TBL] [Abstract][Full Text] [Related]
34. Emerging drugs for narcolepsy.
Abad VC; Guilleminault C
Expert Opin Emerg Drugs; 2004 Nov; 9(2):281-91. PubMed ID: 15571485
[TBL] [Abstract][Full Text] [Related]
35. Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome.
Marti I; Valko PO; Khatami R; Bassetti CL; Baumann CR
Sleep Med; 2009 Dec; 10(10):1146-50. PubMed ID: 19464232
[TBL] [Abstract][Full Text] [Related]
36. Narcolepsy: pathophysiology and pharmacology.
Nishino S
J Clin Psychiatry; 2007; 68 Suppl 13():9-15. PubMed ID: 18078360
[TBL] [Abstract][Full Text] [Related]
37. Narcolepsy: new understanding of irresistible sleep.
Krahn LE; Black JL; Silber MH
Mayo Clin Proc; 2001 Feb; 76(2):185-94. PubMed ID: 11213307
[TBL] [Abstract][Full Text] [Related]
38. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.
Overeem S; Scammell TE; Lammers GJ
Curr Opin Neurol; 2002 Dec; 15(6):739-45. PubMed ID: 12447114
[TBL] [Abstract][Full Text] [Related]
39. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P
Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137
[TBL] [Abstract][Full Text] [Related]
40. [The neurophysiology of cataplexy].
Mayer G
Nervenarzt; 2005 Dec; 76(12):1464, 1466-9. PubMed ID: 16028082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
